BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17880367)

  • 21. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.
    Koch I; Weil R; Wolbold R; Brockmöller J; Hustert E; Burk O; Nuessler A; Neuhaus P; Eichelbaum M; Zanger U; Wojnowski L
    Drug Metab Dispos; 2002 Oct; 30(10):1108-14. PubMed ID: 12228187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
    Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
    Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression?
    Gutmann H; Poller B; Büter KB; Pfrunder A; Schaffner W; Drewe J
    Planta Med; 2006 Jun; 72(8):685-90. PubMed ID: 16755466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and localization of CYP3A4 and CYP3A5 in human lung.
    Anttila S; Hukkanen J; Hakkola J; Stjernvall T; Beaune P; Edwards RJ; Boobis AR; Pelkonen O; Raunio H
    Am J Respir Cell Mol Biol; 1997 Mar; 16(3):242-9. PubMed ID: 9070608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of P-glycoprotein and CYP3A4 along the porcine oral-gastrointestinal tract: implications on oral mucosal drug delivery.
    Gao X; Bhattacharya S; Chan WK; Jasti BR; Upadrashta B; Li X
    Drug Dev Ind Pharm; 2014 May; 40(5):599-603. PubMed ID: 24724914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas.
    Nakamura T; Sakaeda T; Ohmoto N; Tamura T; Aoyama N; Shirakawa T; Kamigaki T; Nakamura T; Kim KI; Kim SR; Kuroda Y; Matsuo M; Kasuga M; Okumura K
    Drug Metab Dispos; 2002 Jan; 30(1):4-6. PubMed ID: 11744604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers.
    Fontana RJ; Lown KS; Paine MF; Fortlage L; Santella RM; Felton JS; Knize MG; Greenberg A; Watkins PB
    Gastroenterology; 1999 Jul; 117(1):89-98. PubMed ID: 10381914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential pharmacokinetic effect of rifampicin on enrofloxacin in broilers: Roles of P-glycoprotein and BCRP induction by rifampicin.
    Guo M; Dai X; Hu D; Zhang Y; Sun Y; Ren W; Wang L
    Poult Sci; 2016 Sep; 95(9):2129-35. PubMed ID: 27118859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies.
    Engman HA; Lennernäs H; Taipalensuu J; Otter C; Leidvik B; Artursson P
    J Pharm Sci; 2001 Nov; 90(11):1736-51. PubMed ID: 11745731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP3A in horse intestines.
    Tydén E; Olsén L; Tallkvist J; Larsson P; Tjälve H
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):112-9. PubMed ID: 15541751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism.
    Westlind-Johnsson A; Malmebo S; Johansson A; Otter C; Andersson TB; Johansson I; Edwards RJ; Boobis AR; Ingelman-Sundberg M
    Drug Metab Dispos; 2003 Jun; 31(6):755-61. PubMed ID: 12756208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta.
    Schuetz JD; Kauma S; Guzelian PS
    J Clin Invest; 1993 Aug; 92(2):1018-24. PubMed ID: 8349787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial dosage adjustment for oral administration of tacrolimus using the intestinal MDR1 level in living-donor liver transplant recipients.
    Masuda S; Goto M; Okuda M; Ogura Y; Oike F; Kiuchi T; Tanaka K; Inui K
    Transplant Proc; 2005 May; 37(4):1728-9. PubMed ID: 15919446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.
    Lown KS; Kolars JC; Thummel KE; Barnett JL; Kunze KL; Wrighton SA; Watkins PB
    Drug Metab Dispos; 1994; 22(6):947-55. PubMed ID: 7895614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue.
    Kivistö KT; Bookjans G; Fromm MF; Griese EU; Münzel P; Kroemer HK
    Br J Clin Pharmacol; 1996 Sep; 42(3):387-9. PubMed ID: 8877031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of genes encoding for drug metabolising cytochrome P450 enzymes and P-glycoprotein in the rat small intestine; comparison to the liver.
    Lindell M; Lang M; Lennernäs H
    Eur J Drug Metab Pharmacokinet; 2003; 28(1):41-8. PubMed ID: 14503663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of cytochrome P450 and MDR1 in patients with proctitis.
    Thörn M; Finnström N; Lundgren S; Rane A; Lööf L
    Ups J Med Sci; 2007; 112(3):303-12. PubMed ID: 18484072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers.
    Yamaori S; Yamazaki H; Iwano S; Kiyotani K; Matsumura K; Saito T; Parkinson A; Nakagawa K; Kamataki T
    Xenobiotica; 2005 Jan; 35(1):69-83. PubMed ID: 15788369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients.
    Kuypers DR; de Jonge H; Naesens M; Lerut E; Verbeke K; Vanrenterghem Y
    Clin Pharmacol Ther; 2007 Dec; 82(6):711-25. PubMed ID: 17495880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.